Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache

Clinical trial NCT04580238 · WITHDRAWN

Trial details

NCT number: NCT04580238
Sponsor: University of Alberta
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Stroke (CVA) or TIA Headache, Migraine Botulinum Toxins, Type A Cerebral Venous Sinus Thrombosis Carotid Dissection Artery Vertebral Dissection Artery Hemorrhagic Stroke Reversible Cerebral Vasoconstriction Syndrome

Start date: 2023-12-01
Primary completion: 2025-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.